FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, updating the product's labeling under NDA 021402.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• SYNTHROID (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for SYNTHROID (LEVOTHYROXINE SODIUM)